Equasens Société anonyme Future Growth
Future criteria checks 2/6
Equasens Société anonyme is forecast to grow earnings and revenue by 11.4% and 6.7% per annum respectively. EPS is expected to grow by 11.7% per annum. Return on equity is forecast to be 17.9% in 3 years.
Key information
11.4%
Earnings growth rate
11.7%
EPS growth rate
Healthcare Services earnings growth | 29.6% |
Revenue growth rate | 6.7% |
Future return on equity | 17.9% |
Analyst coverage | Good |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
The Equasens Société anonyme (EPA:EQS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 03Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Sep 28Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price
Jul 15Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's
Jun 22Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Jun 07Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns
Apr 03At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?
Mar 08Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E
Feb 14Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 27Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?
Nov 29These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely
Oct 28A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Sep 27Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?
Aug 05Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15
Jun 11Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 22Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year
May 08What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?
Apr 04Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends
Feb 13Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)
Jan 26At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?
Dec 21Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?
Dec 07Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital
Nov 12Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?
Oct 27Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?
Oct 12When Should You Buy Equasens Société anonyme (EPA:EQS)?
Sep 09With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case
Aug 24Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively
Jul 28Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05
Jun 10Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05
May 27Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
May 22Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean
Apr 25Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?
Feb 23Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today
Feb 09Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?
Jan 25Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital
Jan 06Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt
Nov 14Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?
Oct 30Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?
Sep 28Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?
Jul 18Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends
Jun 24Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?
Apr 08Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why
Mar 24Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 03Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)
Feb 09Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return
Jan 12What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend
Dec 15Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 250 | 54 | 58 | 71 | 3 |
12/31/2025 | 240 | 47 | 49 | 65 | 6 |
12/31/2024 | 218 | 39 | 40 | 55 | 6 |
6/30/2024 | 215 | 42 | 29 | 49 | N/A |
3/31/2024 | 217 | 45 | 35 | 53 | N/A |
12/31/2023 | 220 | 47 | 39 | 58 | N/A |
6/30/2023 | 223 | 48 | 59 | 71 | N/A |
3/31/2023 | 219 | 47 | 53 | 64 | N/A |
12/31/2022 | 214 | 46 | 47 | 57 | N/A |
6/30/2022 | 203 | 42 | 42 | 51 | N/A |
3/31/2022 | 198 | 41 | 40 | 49 | N/A |
12/31/2021 | 193 | 39 | 37 | 48 | N/A |
9/30/2021 | 190 | 37 | 38 | 51 | N/A |
6/30/2021 | 188 | 35 | 39 | 54 | N/A |
3/31/2021 | 180 | 33 | 33 | 51 | N/A |
12/31/2020 | 172 | 31 | 28 | 47 | N/A |
9/30/2020 | 166 | 29 | 22 | 41 | N/A |
6/30/2020 | 160 | 27 | 17 | 35 | N/A |
3/31/2020 | 159 | 27 | 20 | 38 | N/A |
12/31/2019 | 159 | 27 | 24 | 41 | N/A |
9/30/2019 | 156 | 27 | 23 | 38 | N/A |
6/30/2019 | 153 | 26 | 21 | 36 | N/A |
3/31/2019 | 151 | 26 | 20 | 33 | N/A |
12/31/2018 | 148 | 25 | 18 | 29 | N/A |
9/30/2018 | 144 | 25 | 21 | 31 | N/A |
6/30/2018 | 139 | 24 | 24 | 33 | N/A |
3/31/2018 | 134 | 24 | N/A | 30 | N/A |
12/31/2017 | 130 | 23 | N/A | 27 | N/A |
9/30/2017 | 129 | 22 | N/A | 26 | N/A |
6/30/2017 | 128 | 21 | N/A | 26 | N/A |
3/31/2017 | 128 | 21 | N/A | 24 | N/A |
12/31/2016 | 128 | 21 | N/A | 23 | N/A |
9/30/2016 | 125 | 20 | N/A | 22 | N/A |
6/30/2016 | 121 | 20 | N/A | 22 | N/A |
3/31/2016 | 117 | 19 | N/A | 21 | N/A |
12/31/2015 | 113 | 19 | N/A | 20 | N/A |
9/30/2015 | 113 | 18 | N/A | 20 | N/A |
6/30/2015 | 112 | 18 | N/A | 21 | N/A |
3/31/2015 | 113 | 17 | N/A | 19 | N/A |
12/31/2014 | 115 | 17 | N/A | 17 | N/A |
9/30/2014 | 114 | 17 | N/A | 19 | N/A |
6/30/2014 | 113 | 16 | N/A | 21 | N/A |
3/31/2014 | 113 | 16 | N/A | 17 | N/A |
12/31/2013 | 113 | 16 | N/A | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EQS's forecast earnings growth (11.4% per year) is above the savings rate (1.4%).
Earnings vs Market: EQS's earnings (11.4% per year) are forecast to grow slower than the French market (12.3% per year).
High Growth Earnings: EQS's earnings are forecast to grow, but not significantly.
Revenue vs Market: EQS's revenue (6.7% per year) is forecast to grow faster than the French market (5.5% per year).
High Growth Revenue: EQS's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EQS's Return on Equity is forecast to be low in 3 years time (17.9%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:56 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Equasens Société anonyme is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jean-Baptiste Bouchet | CIC Market Solutions (ESN) |
Robin Leclerc | Degroof Petercam |
Yann de Peyrelongue | Gilbert Dupont |